-
19176-5A selective Aurora kinase inhibitor (IC<sub>50</sub>s = 5, 4, and 1 nM for Aurora A, B, and C, respectively) inhibits the proliferation of 26 different tumor cell lines in vitro and is broadly active in multiple xenograft models.
-
14715-10A competitive antagonist of capsaicin activation of the TRPV1 (IC<sub>50</sub>s = 24.5 and 85.6 nM for human and rat, respectively) reverses thermal and mechanical hyperalgesia in a rat model of inflammatory pain.
-
14715-25A competitive antagonist of capsaicin activation of the TRPV1 (IC<sub>50</sub>s = 24.5 and 85.6 nM for human and rat, respectively) reverses thermal and mechanical hyperalgesia in a rat model of inflammatory pain.
-
14715-5A competitive antagonist of capsaicin activation of the TRPV1 (IC<sub>50</sub>s = 24.5 and 85.6 nM for human and rat, respectively) reverses thermal and mechanical hyperalgesia in a rat model of inflammatory pain.
-
13965-25A cell permeable inhibitor of PRMTs inhibits both yeast Hmt1p and human PRMT1 (IC<sub>50</sub> = 3.0 and 8.
-
13965-5A cell permeable inhibitor of PRMTs inhibits both yeast Hmt1p and human PRMT1 (IC<sub>50</sub> = 3.0 and 8.
-
17774-1A fungal metabolite that inhibits DGAT activity, preventing triacylglycerol formation (IC<sub>50</sub>s = 10.2 and 15.5 µM in rat liver microsomes and Raji cells, respectively.
-
17774-2.5A fungal metabolite that inhibits DGAT activity, preventing triacylglycerol formation (IC<sub>50</sub>s = 10.2 and 15.5 µM in rat liver microsomes and Raji cells, respectively.
-
17775-1A fungal metabolite that inhibits DGAT activity, preventing triacylglycerol formation (IC<sub>50</sub>s = 17.5 and 2.8 µM in rat liver microsomes and Raji cells, respectively).
-
17775-2.5A fungal metabolite that inhibits DGAT activity, preventing triacylglycerol formation (IC<sub>50</sub>s = 17.5 and 2.8 µM in rat liver microsomes and Raji cells, respectively).
-
14398-100A prodrug that through dephosphorylation by alkaline phosphatase is converted to an active thiol, WR 1065 that has free radical scavenging, DNA protective, and hypoxia inducing activities used to selectively reduce toxicity in normal tissues
-
14398-50A prodrug that through dephosphorylation by alkaline phosphatase is converted to an active thiol, WR 1065 that has free radical scavenging, DNA protective, and hypoxia inducing activities used to selectively reduce toxicity in normal tissues